Cyclo-oxygenase-2 and p53 Immunoreactivity in Superficial Early Colorectal Carcinoma.
- Author:
You Sun KIM
1
;
So Dug LIM
;
Jin Kwang LEE
;
Seong Eun KIM
;
Soo Hyung RYU
;
Jung Whan LEE
;
Jeong Seop MOON
Author Information
1. Departments of Internal Medicine, Inje University College of Medicine, Seoul, Korea.
- Publication Type:Original Article ; English Abstract
- Keywords:
Colorectal Neoplasm;
p53;
Cyclo-oxygenase-2
- MeSH:
Adenoma/chemistry/pathology;
Carcinoma/chemistry/pathology;
Colorectal Neoplasms/chemistry/*pathology;
Cyclooxygenase 2/*analysis;
Female;
Humans;
Immunohistochemistry;
Ki-67 Antigen/analysis;
Male;
Middle Aged;
Tumor Markers, Biological/analysis;
Tumor Suppressor Protein p53/*analysis
- From:The Korean Journal of Gastroenterology
2006;47(5):350-356
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND/AIMS: De novo colorectal carcinoma shows more aggressive behavior including submucosal invasiveness. Both p53 and cyclo-oxygenase-2 (COX-2) have been shown to be involved in colon carcinogenesis, progression from adenoma to carcinoma, and submucosal invasion by tumor. We performed this study to evaluate the expression of p53 and COX-2 protein in de novo carcinoma, compared with ex-adenoma carcinoma. METHODS: Twenty three flat adenomas, 19 ex-adenoma carcinomas, 6 de novo carcinomas were included in this study. The expression of p53, COX-2 and Ki-67 were examined immunohistochemically. RESULTS: Both ex- adenoma carcinomas and de novo carcinomas showed similar size and shape. Positive staining for p53 was detected in 3 of 23 (13%) flat adenomas, in 11 of 19 (57.8%) ex-adenoma carcinomas (p<0.05), and in 1 of 6 (16.6%) de novo carcinomas. Increased numbers of COX-2 positive tumor cells were observed in 1 of 23 (4.3%) flat adenomas, in 2 of 19 (10.5%) ex-adenoma carcinomas, and in 3 of 6 (50%) de novo carcinomas. COX-2 positive expression showed increased tendency in de novo carcinoma (p=0.073). There was no correlation between COX-2, p53, and Ki-67 expression. CONCLUSION: De novo carcinoma shows increased tendency of COX-2 expression, but decreased p53 expression when compared to ex-adenoma carcinoma. These immunohistochemical findings are in accordance with the fact that de novo carcinoma has no preceding adenoma, with more frequent submucosal invasion despite the small lesion size.
